HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015

Julia M.L. Brotherton, Karen L. Winch, Genevieve Chappell, Carolyn Banks, Dennis Meijer, Sonya Ennis, Karen Peterson, Rosalind Webby, Lisa J. Whop

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objective: To estimate human papillomavirus (HPV) vaccination coverage and course completion rates for Indigenous adolescents in four Australian states and territories.

Participants, setting: Adolescents who were 12 years old in 2015 and received the quadrivalent HPV vaccine (three doses: 0, 2, 6 months) as part of the National HPV Vaccination Program in 2015 or 2016 in New South Wales, Queensland, the Northern Territory, or the Australian Capital Territory.

Main outcome measures: Estimated HPV vaccination coverage by dose and by Indigenous status and sex, based on National HPV Vaccination Program Register data; vaccination course completion rates (proportion of dose 1 recipients who received dose 3) for 12-year-olds vaccinated during 2013–2016, by sex, jurisdiction, and Indigenous status.

Results: Dose 1 coverage exceeded 80% for all Indigenous status/jurisdiction/sex groups (range, 83.3–97.7%). Coverage was similar for Indigenous and non-Indigenous girls in Queensland (87.3% v 87.0%), lower for Indigenous girls in the ACT (88.7% v 97.7%) and the NT (91.1% v 97.0%), and higher in NSW (95.9% v 89.9%); it was similar for Indigenous and non-Indigenous boys in all jurisdictions except the NT (88.6% v 96.3%). Dose 3 coverage (range, 61.2–87.7%) was markedly lower for Indigenous than non-Indigenous 12-year-olds in all jurisdictions, except for girls in NSW (82.6% v 83.6%).

Conclusion: HPV vaccine coverage is high, but course completion is generally lower for Indigenous adolescents. Strategies for improving completion rates for Indigenous Australians are needed to end the higher burden of cervical cancer among Indigenous than non-Indigenous women.

Original languageEnglish
Pages (from-to)31-36
Number of pages6
JournalMedical Journal of Australia
Volume211
Issue number1
Early online date9 Jun 2019
DOIs
Publication statusPublished - Jul 2019

Fingerprint

Vaccination
Papillomavirus Vaccines
Queensland
Australian Capital Territory
Northern Territory
New South Wales
Uterine Cervical Neoplasms
Outcome Assessment (Health Care)

Cite this

Brotherton, Julia M.L. ; Winch, Karen L. ; Chappell, Genevieve ; Banks, Carolyn ; Meijer, Dennis ; Ennis, Sonya ; Peterson, Karen ; Webby, Rosalind ; Whop, Lisa J. / HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015. In: Medical Journal of Australia. 2019 ; Vol. 211, No. 1. pp. 31-36.
@article{d79871f04e314aa2a850adc59fe14190,
title = "HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015",
abstract = "Objective: To estimate human papillomavirus (HPV) vaccination coverage and course completion rates for Indigenous adolescents in four Australian states and territories. Participants, setting: Adolescents who were 12 years old in 2015 and received the quadrivalent HPV vaccine (three doses: 0, 2, 6 months) as part of the National HPV Vaccination Program in 2015 or 2016 in New South Wales, Queensland, the Northern Territory, or the Australian Capital Territory. Main outcome measures: Estimated HPV vaccination coverage by dose and by Indigenous status and sex, based on National HPV Vaccination Program Register data; vaccination course completion rates (proportion of dose 1 recipients who received dose 3) for 12-year-olds vaccinated during 2013–2016, by sex, jurisdiction, and Indigenous status. Results: Dose 1 coverage exceeded 80{\%} for all Indigenous status/jurisdiction/sex groups (range, 83.3–97.7{\%}). Coverage was similar for Indigenous and non-Indigenous girls in Queensland (87.3{\%} v 87.0{\%}), lower for Indigenous girls in the ACT (88.7{\%} v 97.7{\%}) and the NT (91.1{\%} v 97.0{\%}), and higher in NSW (95.9{\%} v 89.9{\%}); it was similar for Indigenous and non-Indigenous boys in all jurisdictions except the NT (88.6{\%} v 96.3{\%}). Dose 3 coverage (range, 61.2–87.7{\%}) was markedly lower for Indigenous than non-Indigenous 12-year-olds in all jurisdictions, except for girls in NSW (82.6{\%} v 83.6{\%}). Conclusion: HPV vaccine coverage is high, but course completion is generally lower for Indigenous adolescents. Strategies for improving completion rates for Indigenous Australians are needed to end the higher burden of cervical cancer among Indigenous than non-Indigenous women.",
keywords = "Papillomavirus infections, Uterine cervical neoplasms, Vaccination",
author = "Brotherton, {Julia M.L.} and Winch, {Karen L.} and Genevieve Chappell and Carolyn Banks and Dennis Meijer and Sonya Ennis and Karen Peterson and Rosalind Webby and Whop, {Lisa J.}",
year = "2019",
month = "7",
doi = "10.5694/mja2.50221",
language = "English",
volume = "211",
pages = "31--36",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "Australasian Medical Publishing Company",
number = "1",

}

Brotherton, JML, Winch, KL, Chappell, G, Banks, C, Meijer, D, Ennis, S, Peterson, K, Webby, R & Whop, LJ 2019, 'HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015', Medical Journal of Australia, vol. 211, no. 1, pp. 31-36. https://doi.org/10.5694/mja2.50221

HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015. / Brotherton, Julia M.L.; Winch, Karen L.; Chappell, Genevieve; Banks, Carolyn; Meijer, Dennis; Ennis, Sonya; Peterson, Karen; Webby, Rosalind; Whop, Lisa J.

In: Medical Journal of Australia, Vol. 211, No. 1, 07.2019, p. 31-36.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015

AU - Brotherton, Julia M.L.

AU - Winch, Karen L.

AU - Chappell, Genevieve

AU - Banks, Carolyn

AU - Meijer, Dennis

AU - Ennis, Sonya

AU - Peterson, Karen

AU - Webby, Rosalind

AU - Whop, Lisa J.

PY - 2019/7

Y1 - 2019/7

N2 - Objective: To estimate human papillomavirus (HPV) vaccination coverage and course completion rates for Indigenous adolescents in four Australian states and territories. Participants, setting: Adolescents who were 12 years old in 2015 and received the quadrivalent HPV vaccine (three doses: 0, 2, 6 months) as part of the National HPV Vaccination Program in 2015 or 2016 in New South Wales, Queensland, the Northern Territory, or the Australian Capital Territory. Main outcome measures: Estimated HPV vaccination coverage by dose and by Indigenous status and sex, based on National HPV Vaccination Program Register data; vaccination course completion rates (proportion of dose 1 recipients who received dose 3) for 12-year-olds vaccinated during 2013–2016, by sex, jurisdiction, and Indigenous status. Results: Dose 1 coverage exceeded 80% for all Indigenous status/jurisdiction/sex groups (range, 83.3–97.7%). Coverage was similar for Indigenous and non-Indigenous girls in Queensland (87.3% v 87.0%), lower for Indigenous girls in the ACT (88.7% v 97.7%) and the NT (91.1% v 97.0%), and higher in NSW (95.9% v 89.9%); it was similar for Indigenous and non-Indigenous boys in all jurisdictions except the NT (88.6% v 96.3%). Dose 3 coverage (range, 61.2–87.7%) was markedly lower for Indigenous than non-Indigenous 12-year-olds in all jurisdictions, except for girls in NSW (82.6% v 83.6%). Conclusion: HPV vaccine coverage is high, but course completion is generally lower for Indigenous adolescents. Strategies for improving completion rates for Indigenous Australians are needed to end the higher burden of cervical cancer among Indigenous than non-Indigenous women.

AB - Objective: To estimate human papillomavirus (HPV) vaccination coverage and course completion rates for Indigenous adolescents in four Australian states and territories. Participants, setting: Adolescents who were 12 years old in 2015 and received the quadrivalent HPV vaccine (three doses: 0, 2, 6 months) as part of the National HPV Vaccination Program in 2015 or 2016 in New South Wales, Queensland, the Northern Territory, or the Australian Capital Territory. Main outcome measures: Estimated HPV vaccination coverage by dose and by Indigenous status and sex, based on National HPV Vaccination Program Register data; vaccination course completion rates (proportion of dose 1 recipients who received dose 3) for 12-year-olds vaccinated during 2013–2016, by sex, jurisdiction, and Indigenous status. Results: Dose 1 coverage exceeded 80% for all Indigenous status/jurisdiction/sex groups (range, 83.3–97.7%). Coverage was similar for Indigenous and non-Indigenous girls in Queensland (87.3% v 87.0%), lower for Indigenous girls in the ACT (88.7% v 97.7%) and the NT (91.1% v 97.0%), and higher in NSW (95.9% v 89.9%); it was similar for Indigenous and non-Indigenous boys in all jurisdictions except the NT (88.6% v 96.3%). Dose 3 coverage (range, 61.2–87.7%) was markedly lower for Indigenous than non-Indigenous 12-year-olds in all jurisdictions, except for girls in NSW (82.6% v 83.6%). Conclusion: HPV vaccine coverage is high, but course completion is generally lower for Indigenous adolescents. Strategies for improving completion rates for Indigenous Australians are needed to end the higher burden of cervical cancer among Indigenous than non-Indigenous women.

KW - Papillomavirus infections

KW - Uterine cervical neoplasms

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85067341840&partnerID=8YFLogxK

U2 - 10.5694/mja2.50221

DO - 10.5694/mja2.50221

M3 - Article

VL - 211

SP - 31

EP - 36

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 1

ER -